Cargando…

Emerging infectious diseases : clinical case studies /

More than 30 newly emerged microorganisms and related diseases have been discovered in the past 20 years. Since these infections are so new, even infectious diseases experts and clinical microbiologists need more information. This book covers recently emerged infectious diseases based on real cases...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Erg�on�ul, �Onder (Editor ), Can, F�usun (Editor ), Akova, Murat (Editor ), Madoff, Lawrence (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: London : Academic Press, 2014.
Colección:Developments in emerging and existing infectious diseases ; 1.
Temas:
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Front Cover; Emerging Infectious Diseases; Copyright Page; Dedication; Contents; List of Contributors; Preface; 1. Severe Fever with Thrombocytopenia Syndrome Associated with a Novel Bunyavirus; Case Presentation; 1. Why this Case was Significantly Important as an Emerging Infection; 2. What is the Causative Agent?; 3. What is the Frequency of the Disease in Endemic Regions?; 4. How is the Virus Transmitted?; 5. What are the Clinical Manifestations of the Disease?; 6. What are the Mechanisms of Pathogenesis?; 7. How do you Diagnose the Infection?
  • 8. How do you Differentiate the Infection from Similar Clinical Manifestations?9. What are the Therapeutic Approaches?; 10. What are the Preventive and Infection Control Measures?; Acknowledgments; References; 2. Bas-Congo Virus: A Novel Rhabdovirus Associated with Acute Hemorrhagic Fever; Clinical Presentation; Epidemiological Context; Laboratory Investigation for Viral Hemorrhagic Fever (VHF) Diagnosis; Discovery of Bas-Congo Virus, a Novel Rhabdovirus, in Patient Serum; 1. Why this Case was Significantly Important as an Emerging Infection; 2. What is the Causative Agent?
  • 2.1 BASV as the Etiologic Agent of an Acute Hemorrhagic Fever Syndrome2.2 BASV Taxonomy; 2.3 Virus Description; 3. What is the Frequency of the Disease?; 4. How is the Virus Transmitted?; 5. What are the Clinical Manifestations?; 6. How do you Diagnose?; 6.1 Molecular Diagnosis; 6.2 Viral Isolation; 6.3 Serologic Diagnosis; 7. How do you Differentiate this Disease from Similar Entities?; 8. What is the Therapeutic Approach?; 9. What are the Preventive and Infection Control Measures?; References; 3. Hantavirus Infections; Case Presentation.
  • 1. Why this Case was Significantly Important as an Emerging Infection2. What is the Causative Agent?; 3. What is the Frequency of the Disease?; 4. How is the Virus Transmitted?; 5. Which Factors are Involved in Disease Pathogenesis? What are the Pathogenic Mechanisms?; 6. What are the Clinical Manifestations?; 7. How do you Diagnose?; 8. How do you Differentiate this Disease from Similar Entities?; 9. What is the Therapeutic Approach?; 10. What are the Preventive and Infection Control Measures?; References; 4. Lassa Fever; Case Presentation.
  • 1. Why Lassa Fever is Important as an Emerging Infection2. What is the Causative Agent?; 3. What is the Frequency of the Disease?; 4. How is the Virus Transmitted?; 5. Which Factors are Involved in Disease Pathogenesis? What are the Pathogenic Mechanisms?; 6. What are the Clinical Manifestations?; 7. How do you Make the Diagnosis?; 8. How do you Differentiate this Disease from Similar Entities?; 9. What is the Therapeutic Approach?; 10. What are the Preventive and Infection Control Measures?; References; 5. Alkhurma Hemorrhagic Fever; Case Presentation.